Effects of chronic jetlag on high-fat and high-fructose diet induced renal injury in mice

This mouse study asked whether the body-clock disruption caused by chronic jet lag makes kidney disease worse in animals already eating an unhealthy, obesity-promoting diet. Researchers fed mice a high-fat, high-fructose diet (HFHFD) to induce obesity-related kidney disease, then layered on repeated light–dark cycle shifts to mimic the circadian disruption experienced by frequent travellers or shift workers. Compared to diet alone, the combined insult — chronic jet lag plus HFHFD — produced greater weight gain, worse blood-sugar regulation, higher urinary protein (a marker of kidney damage), and more severe microscopic kidney damage including scarring of the glomeruli, tubular degeneration, and podocyte (filtration cell) injury. The researchers identified a likely molecular culprit: activation of the NLRP3 inflammasome, a key driver of sterile inflammation, whose protein products (NLRP3, Caspase-1, IL-1β) were markedly elevated in the combined-insult group and statistically correlated with the degree of kidney scarring and fibrosis. Circadian clock gene rhythms within kidney tissue were also blunted, suggesting the organ's own time-keeping machinery was compromised. The findings position chronic circadian misalignment as an independent amplifier of obesity-related kidney disease — not merely a bystander. For clinicians, this raises the question of whether managing shift-work schedules or sleep disruption could be a meaningful adjunct strategy in patients with obesity-related kidney risk.

• Chronic jet lag (periodic light–dark cycle reversal) significantly worsened body weight gain and glucose intolerance in HFHFD-fed mice relative to diet alone, indicating additive metabolic harm from circadian disruption.
• Urinary protein excretion — a functional indicator of glomerular injury — was markedly elevated in the HFHFD + jet lag group, accompanied by histological evidence of aggravated glomerular hypertrophy, glomerulosclerosis, tubular degeneration, and podocyte injury.
• Renal expression of NLRP3, Caspase-1, and IL-1β was substantially upregulated by combined jet lag and diet stress, and these inflammasome markers positively correlated with the degree of glomerulosclerosis and renal fibrosis, suggesting mechanistic linkage rather than coincidental co-elevation.
• Circadian clock gene rhythms within kidney tissue were disrupted in jetlag-exposed mice, indicating that the organ's intrinsic time-keeping is a direct target of chronic light–dark cycle misalignment, independent of systemic metabolic effects.

This was a controlled preclinical experiment using adult male mice assigned to four groups: standard diet, HFHFD, standard diet plus chronic jet lag (periodic 12-hour light–dark phase advances), and HFHFD plus chronic jet lag. Jet lag was simulated by repeated, scheduled light–dark cycle alterations over a chronic exposure period designed to model real-world circadian disruption. Outcomes included metabolic parameters (body weight, serum lipids, glucose tolerance), renal functional markers (urinary protein), histopathological scoring of kidney sections, and protein/gene expression analysis of circadian clock genes and NLRP3 inflammasome components. Specific group sizes and the total study duration are not reported in the abstract.

As an animal model study, findings cannot be directly extrapolated to humans; the jet lag paradigm (controlled light–dark shifts) is a simplified proxy for the heterogeneous circadian disruption experienced by shift workers or frequent travellers. The study does not establish causality between NLRP3 activation and renal injury — pharmacological or genetic inhibition of NLRP3 in this model would be the critical next experiment to confirm mechanistic necessity. Female sex, different dietary compositions, or varying durations and severities of circadian disruption were not explored, limiting generalisability. Translational dose–response data (e.g., how many phase shifts per week produce measurable renal harm) are absent, which is essential for any eventual clinical framing.

This study extends the circadian-metabolic disease literature represented in this corpus by demonstrating a specific organ-level consequence — renal inflammasome activation — of chronic light–dark misalignment, complementing the mechanistic circadian work reviewed in [§44] on CLOCK-BMAL1 biology and therapeutic targeting. It parallels [§133], which examines how light exposure and circadian disruption drive central oxidative stress, by showing that peripheral organs such as the kidney are equally vulnerable to clock misalignment, albeit through distinct inflammatory (NLRP3) rather than purely oxidative mechanisms. The NLRP3/IL-1β pathway implicated here also connects thematically to [§109], which investigates macrophage polarization and inflammatory signaling in obstructive sleep apnea-related metabolic disease, suggesting that innate immune inflammasome cascades are a shared downstream effector across multiple forms of sleep and circadian disruption. Finally, the renal-injury phenotype reported here provides an organ-specific mechanistic counterpart to the broader metabolic dysfunction outcomes studied in [§111], which uses suprachiasmatic nucleus stimulation to correct circadian-driven metabolic disease, underscoring that circadian realignment may be therapeutically relevant to kidney protection in obese patients.

• The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting
  Directly relevant mechanistic context: this article reviews the CLOCK-BMAL1 molecular machinery whose disruption underlies the renal circadian gene rhythm loss described in the jet lag study.
• Sleep, Light, Circadian, Central Oxidative Stress
  Same upstream stressor (circadian/light disruption) but examines oxidative stress in the CNS rather than NLRP3-driven inflammation in the kidney — comparing the two clarifies how organ-specific the downstream pathways are.
• METTL14 Regulates Adipose Tissue Macrophage Polarization via JAK2 / STAT3 Pathway to Attenuate Obstructive Sleep Apnea‐Related Systemic Inflammation
  Both studies implicate innate immune inflammatory signaling (NLRP3/macrophage polarization) as the bridge between sleep-circadian disruption and metabolic organ injury, but in different disease contexts (jet lag + diet vs. obstructive sleep apnea).
• Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
  Provides therapeutic contrast: if SCN stimulation can reverse circadian-driven metabolic dysfunction, this raises the testable hypothesis that circadian realignment could also attenuate the renal injury amplification demonstrated in the jet lag model.
• TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
  Time-restricted eating as a circadian-aligned dietary intervention offers a conceptual counter-model to the circadian disruption + unhealthy diet combination studied here, making direct mechanistic comparison valuable for identifying protective versus harmful dietary-timing interactions.